Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to compare the efficacy and safety of palifermin on reducing mucositis for patients receiving autologous or allogeneic stem cell transplantation with supportive care.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Mucositis

Clinical Trial Details

NCT number	NCT02313792
Study type	Interventional
Source	The Catholic University of Korea
Contact
Status	Not yet recruiting
Phase	Phase 3
Start date	January 2015
Completion date	June 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02252926` - Local Anesthetic Treatment of Oral Pain in Patients With Mucositis	Phase 2
Completed	`NCT01155609` - L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer	N/A
Completed	`NCT00357942` - Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy	Phase 4
Completed	`NCT00360685` - Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX	N/A
Completed	`NCT04586491` - The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients	N/A
Withdrawn	`NCT02589860` - Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant
Not yet recruiting	`NCT02506231` - The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome	Phase 2/Phase 3
Completed	`NCT02605382` - Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis	Phase 2
Completed	`NCT02639377` - Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis and Gingivitis	Phase 2
Completed	`NCT00956254` - Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis	Phase 3
Terminated	`NCT02575313` - The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck Cancer	Phase 1/Phase 2
Completed	`NCT00584597` - A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis	Phase 1
Enrolling by invitation	`NCT05590117` - Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer	Early Phase 1
Completed	`NCT05635929` - Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients.	N/A
Completed	`NCT05181943` - Effectiveness of Photo-biomodulation in the Treatment of Chemotherapy Induced Mucositis	N/A
Completed	`NCT03713567` - Clinical, Immunological and Microbiological Evaluation of Experimental Gingivitis and Peri-implant Mucositis	N/A
Completed	`NCT02671812` - Outcome After Dental Implant Treatment
Terminated	`NCT02273752` - Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer	Phase 2
Recruiting	`NCT01707641` - Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer	Phase 4
Completed	`NCT01015183` - Prevention Chemotherapy Induced Mucositis by Zinc Sulfate	Phase 2/Phase 3